Nature of Glutamate Alterations in Schizophrenia: A Meta-analysis of Proton Magnetic Resonance Spectroscopy Studies

Merritt, Kate, Egerton, Alice, Kempton, Matthew J., Taylor, Matthew J., McGuire, Philip K.·2016·JAMA Psychiatry

DOI 10.1001/jamapsychiatry.2016.0442

Cited by (367)

Items 101–200 of 367

JNK signalling mediates aspects of maternal immune activation: importance of maternal genotype in relation to schizophrenia risk
Rebecca L. Openshaw, Jaedeok Kwon, Alison McColl, Josef Martin Penninger, Jonathan Cavanagh, Judith A. Pratt, BRIAN J. MORRIS · 2019 · Journal of Neuroinflammation
Treatment effects on neurometabolite levels in schizophrenia: A systematic review and meta-analysis of proton magnetic resonance spectroscopy studies
Manabu Kubota, Sho Moriguchi, Keisuke Takahata, Shinichiro Nakajima, Nobuyuki Horita · 2020 · Schizophrenia Research
Cannabidiol modulation of hippocampal glutamate in early psychosis
Aisling O’Neill, Luciano Annibale, Grace Blest‐Hopley, Robin Paul Wilson, Vincent Giampietro, Sagnik Bhattacharyya · 2021 · Journal of Psychopharmacology
Is Memantine Effective as an NMDA Receptor Antagonist in Adjunctive Therapy for Schizophrenia?
Tetsuro Kikuchi · 2020 · Biomolecules
Consensus on potential biomarkers developed for use in clinical tests for schizophrenia
Ping Lin, Junyu Sun, Xiaoyan Lou, Dan Li, Yun Shi, Zhenhua Li, Peijun Ma, Ping Li, Shuzi Chen, Weifeng Jin et al. · 2022 · General Psychiatry
Magnetic Resonance Spectroscopy Studies of Brain Energy Metabolism in Schizophrenia: Progression from Prodrome to Chronic Psychosis
Abigail Stein, Chenyanwen Zhu, Fei Du, Döst Öngür · 2023 · Current Psychiatry Reports
Remission from antipsychotic treatment in first episode psychosis related to longitudinal changes in brain glutamate
Kate Merritt, Rocío Pérez‐Iglesias, Kyra-Verena Sendt, Alexiοs Arvanitis, Sameer Jauhar, Fiona Pepper, Gareth J. Barker, Birte Yding Glenthoj, Celso Arango, Shôn W. Lewis et al. · 2019 · Schizophrenia
Dopamine and glutamate in individuals at high risk for psychosis: a meta‐analysis of in vivo imaging findings and their variability compared to controls
Robert Ali McCutcheon, Kate Merritt, Oliver David Howes · 2021 · World Psychiatry
Reversal and Preventive Pleiotropic Mechanisms Involved in the Antipsychotic-Like Effect of Taurine, an Essential β-Amino Acid in Ketamine-Induced Experimental Schizophrenia in Mice
Benneth Ben‐Azu, Christian I. Uruaka, Abayomi Mayowa Ajayi, Theophilus Aghogho Jarikre, Eze Kingsley Nwangwa, Kingsley Chimsorom Chilaka, Bienose S. Chijioke, Marymagdalene G. Omonyeme, Chineye B. Ozege, Emmanuella C. Ofili et al. · 2022 · Neurochemical Research
Corticolimbic hyper-response to emotion and glutamatergic function in people with high schizotypy: a multimodal fMRI-MRS study
Gemma Modinos, Anna Patricia McLaughlin, Alice Egerton, Katrina McMullen, Veena Kumari, Gareth J. Barker, Christian Keysers, Steven Williams · 2017 · Translational Psychiatry
Anterior cingulate glutamate metabolites as a predictor of antipsychotic response in first episode psychosis: data from the STRATA collaboration
Alice Egerton, Kira Griffiths, Cecila Casetta, J.F.W. Deakin, Richard Drake, Oliver David Howes, Laura Kassoumeri, Sobia Khan, Steve Lankshear, Jane Lees et al. · 2022 · Neuropsychopharmacology
Decoupling of Brain Temperature and Glutamate in Recent Onset of Schizophrenia: A 7T Proton Magnetic Resonance Spectroscopy Study
Sotirios Posporelis, Jennifer Marie Coughlin, Anouk Marsman, Subechhya Pradhan, Teppei Tanaka, Hongxing Wang, Mark Varvaris, Rebecca E. Ward, Cecilia P. Higgs, Jamie A. Edwards et al. · 2017 · Biological Psychiatry Cognitive Neuroscience and Neuroimaging
Antibodies in the Diagnosis, Prognosis, and Prediction of Psychotic Disorders
Thomas Arthur Pollak, Jonathan P. Rogers, Robert G. Nagele, Mark Peakman, James M. Stone, Anthony S. David, Philip K. McGuire · 2018 · Schizophrenia Bulletin
Effects of N-acetylcysteine on brain glutamate levels and resting perfusion in schizophrenia
Grant McQueen, John Lally, Tracy Collier, Fernando O. Zelaya, David J. Lythgoe, Gareth J. Barker, James M. Stone, Philip K. McGuire, James Hunter MacCabe, Alice Egerton · 2018 · Psychopharmacology
A Longitudinal Multimodal Neuroimaging Study to Examine Relationships Between Resting State Glutamate and Task Related BOLD Response in Schizophrenia
Elyse J. Cadena, David Matthew White, Nina Vanessa Kraguljac, Meredith Amanda Reid, Jose Omar Maximo, Eric A. Nelson, Brian A. Gawronski, Adrienne Carol Lahti · 2018 · Frontiers in Psychiatry
Emerging Temporal Lobe Dysfunction in People at Clinical High Risk for Psychosis
P. Allen, H. Moore, C. Corcoran, J. Gilleen, P. Kozhuharova, A. Reichenberg, D. Malaspina · 2019 · Frontiers in Psychiatry
Sleep quality is related to brain glutamate and symptom severity in schizophrenia
Stephanie A. Korenic, Elizabeth A. Klingaman, Emerson M. Wickwire, Frank E. Gaston, Hongji Chen, S. Andrea Wijtenburg, Laura M. Rowland · 2019 · Journal of Psychiatric Research
Hippocampal neuroanatomy in first episode psychosis: A putative role for glutamate and serotonin receptors
Min Tae M Park, Peter Jeon, ALI RAZA KHAN, Kara Dempster, M. Mallar Chakravarty, Jason P. Lerch, Michael Mackinley, Jean Théberge, Lena K. Palaniyappan · 2021 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
Reducedγ-Aminobutyric Acid and Glutamate+Glutamine Levels in Drug-Naïve Patients with First-Episode Schizophrenia but Not in Those at Ultrahigh Risk
Jijun Wang, Yingying Tang, Tianhong Zhang, HuiRu Cui, Lihua Xu, Botao Zeng, Yu Li, Gaiying Li, Chunbo Li, Hui Liu et al. · 2016 · Neural Plasticity
Cognitive control network connectivity differentially disrupted in treatment resistant schizophrenia
Charlotte Mary Horne, Lucy D. Vanes, Tess Verneuil, Elias D. Mouchlianitis, Timea Szentgyorgyi, Bruno B. Averbeck, Robert Leech, Rosalyn Moran, Sukhwinder Singh Shergill · 2021 · NeuroImage Clinical
Excitatory/Inhibitory Imbalance Underlies Hippocampal Atrophy in Individuals With 22q11.2 Deletion Syndrome With Psychotic Symptoms
Valentina Mancini, Muhammad G. Saleh, Farnaz Delavari, Joëlle Bagautdinova, Stéphan Eliez · 2023 · Biological Psychiatry
Association between serum levels of glutamate and neurotrophic factors and response to clozapine treatment
Krivoy, Amir, Hochman, Eldar, Sendt, Kyra-Verena, Hollander, Sarah, Vilner, Yael, Selakovic, Mirjana, Weizman, Abraham, Taler, Michal · 2018 · Schizophrenia Research
Dysfunction of the NMDA Receptor in the Pathophysiology of Schizophrenia and/or the Pathomechanisms of Treatment-Resistant Schizophrenia
Ruri Okubo, Motohiro Okada, Eishi Motomura · 2024 · Biomolecules
Association of Cortical Glutamate and Working Memory Activation in Patients With Schizophrenia: A Multimodal Proton Magnetic Resonance Spectroscopy and Functional Magnetic Resonance Imaging Study
Jakob André Kaminski, Tobias Gleich, Yu Fukuda, Teresa Katthagen, Jürgen Gallinat, Andreas Heinz, Florian Schlagenhauf · 2019 · Biological Psychiatry
Progressive Changes in Glutamate Concentration in Early Stages of Schizophrenia: A Longitudinal 7-Tesla MRS Study
Peter Jeon, Roberto Limongi, Sabrina D. Ford, Michael Mackinley, Kara Dempster, Jean Théberge, Lena K. Palaniyappan · 2020 · Schizophrenia Bulletin Open
Cannabis use in early psychosis is associated with reduced glutamate levels in the prefrontal cortex
Silvia Rigucci, Lijing Xin, Paul Klauser, Philipp Baumann, Luis Alameda, Martine Cleusix, Raoul Jenni, Carina Ferrari, Maurizio Pompili, Rolf Gruetter A et al. · 2017 · Psychopharmacology
Postural Sway Abnormalities in Schizotypal Personality Disorder
Deborah Apthorp, Amanda R. Bolbecker, Lisa A. Bartolomeo, Brian F. O’Donnell, William P. Hetrick · 2018 · Schizophrenia Bulletin
Markers of glutamate and GABA neurotransmission in the prefrontal cortex of schizophrenia subjects: Disease effects differ across anatomical levels of resolution
Samuel J. Dienel, John F. Enwright, Gil D. Hoftman, David A. Lewis · 2019 · Schizophrenia Research
Intra-Regional Glu-GABA vs Inter-Regional Glu-Glu Imbalance: A 1H-MRS Study of the Neurochemistry of Auditory Verbal Hallucinations in Schizophrenia
H. Hjelmervik, A. Craven, Igne Sinceviciute, E. Johnsen, K. Kompus, J. Bless, R. Kroken, E. Løberg, L. Ersland, R. Grüner et al. · 2019 · Schizophrenia bulletin
Can N-Methyl-D-Aspartate Receptor Hypofunction in Schizophrenia Be Localized to an Individual Cell Type?
Alexei M. Bygrave, Kasyoka Kilonzo, Dimitri Michael Kullmann, David M. Bannerman, Dennis Kätzel · 2019 · Frontiers in Psychiatry
Ultrastructural evidence for glutamatergic dysregulation in schizophrenia
Rosalinda C. Roberts, Lesley A. McCollum, Kirsten E. Schoonover, Samuel J. Mabry, Joy K. Roche, Adrienne Carol Lahti · 2020 · Schizophrenia Research
Glutamate in the Dorsolateral Prefrontal Cortex in Patients With Schizophrenia: A Meta-analysis of 1H-Magnetic Resonance Spectroscopy Studies
Jakob André Kaminski, Lea Mascarell-Maricic, Yu Fukuda, Teresa Katthagen, Andreas Heinz, Florian Schlagenhauf · 2020 · Biological Psychiatry
The potential of 1H-MRS in CNS drug development
Alice Egerton · 2019 · Psychopharmacology
Brain glutamate concentration in men with early psychosis: a magnetic resonance spectroscopy case–control study at 7 T
Beata R. Godlewska, Amedeo Minichino, Uzay E. Emir, Ilinca Angelescu, Belinda Lennox, Masa Micunovic, Oliver David Howes, Philip J. Cowen · 2021 · Translational Psychiatry
Multimodal MRI assessment for first episode psychosis: A major change in the thalamus and an efficient stratification of a subgroup
Andreia Vasconcellos Faria, Yi Zhao, Chenfei Ye, Johnny Hsu, Kun Yang, Elizabeth Cifuentes, Lei Wang, Susumu Mori, Michael Miller, Brian C. Caffo et al. · 2020 · Human Brain Mapping
Heritability of cerebral glutamate levels and their association with schizophrenia spectrum disorders: a 1[H]-spectroscopy twin study
Christian Stefan Legind, Brian Villumsen Broberg, René C.W. Mandl, Rachel M. Brouwer, Simon Jesper Anhøj, Rikke W. Hilker, Maria H. Jensen, Philip K. McGuire, Hilleke E. Hulshoff Pol, Birgitte Fagerlund et al. · 2018 · Neuropsychopharmacology
Functional magnetic resonance spectroscopy in patients with schizophrenia and bipolar affective disorder: Glutamate dynamics in the anterior cingulate cortex during a working memory task
Luke A. Jelen, Sinéad King, Charlotte Mary Horne, David J. Lythgoe, Allan Hunter Young, James M. Stone · 2018 · European Neuropsychopharmacology
Salience network glutamate and brain connectivity in medication-naïve first episode patients – A multimodal magnetic resonance spectroscopy and resting state functional connectivity MRI study
Jose Omar Maximo, Frédéric Briend, William P. Armstrong, Nina Vanessa Kraguljac, Adrienne Carol Lahti · 2021 · NeuroImage Clinical
Towards a neurodynamical understanding of the prodrome in schizophrenia
Emmi Mikanmaa, Tineke Grent-‘t-Jong, Lingling Hua, Marc Recasens, Hanna Thuné, Peter J. Uhlhaas · 2017 · NeuroImage
Dystrophin deficiency leads to dysfunctional glutamate clearance in iPSC derived astrocytes
Abdulsamie M. Patel, Keimpe D. B. Wierda, Lieven Thorrez, Maaike van Putten, Jonathan De Smedt, Luís F. Ribeiro, Tine Tricot, Madhavsai K. Gajjar, Robin Duelen, Philip Van Damme et al. · 2019 · Translational Psychiatry
Reduced resting state functional connectivity in the hippocampus-midbrain-striatum network of schizophrenia patients
Shiral S. Gangadin, Wiepke Cahn, Thomas W. Scheewe, Hilleke E. Hulshoff Pol, Matthijs Geert Bossong · 2021 · Journal of Psychiatric Research
Neuroanatomical changes in people with high schizotypy: relationship to glutamate levels
Gemma Modinos, Alice Egerton, Anna Patricia McLaughlin, Katrina McMullen, Veena Kumari, David J. Lythgoe, Gareth J. Barker, André Aleman, Steven Williams · 2017 · Psychological Medicine
Oxytocin modulates hippocampal perfusion in people at clinical high risk for psychosis
Cathy Davies, Yannis Paloyelis, Grazia Rutigliano, Marco Cappucciati, Andrea De Micheli, Valentina Ramella‐Cravaro, Umberto Provenzani, Mathilde Antoniades, Gemma Modinos, Dominic Oliver et al. · 2019 · Neuropsychopharmacology
Ketamine for psychotic depression: An overview of the glutamatergic system and ketamine's mechanisms associated with antidepressant and psychotomimetic effects
Tuyen T. Le, Joshua D. Di Vincenzo, Kayla M. Teopiz, Yena L. Lee, Danielle S. Cha, Leanna M.W. Lui, Nelson B. Rodrigues, Roger Ho, Bing Cao, Kangguang Lin et al. · 2021 · Psychiatry Research
IUPHAR themed review: The gut microbiome in schizophrenia
Srinivas Kamath, Elysia Sokolenko, Kate Collins, Nicole S.L. Chan, Natalie T. Mills, Scott Richard Clark, Francine Z. Marques, Paul Joyce · 2024 · Pharmacological Research
Inefficient neural system stabilization: a theory of spontaneous resolutions and recurrent relapses in psychosis
Lena K. Palaniyappan · 2019 · Journal of Psychiatry and Neuroscience
The Cannabinoid CB1 Receptor in Schizophrenia
Faith Borgan, Michelle Kokkinou, Oliver David Howes · 2020 · Biological Psychiatry Cognitive Neuroscience and Neuroimaging
Effects of acute N-acetylcysteine challenge on cortical glutathione and glutamate in schizophrenia: A pilot in vivo proton magnetic resonance spectroscopy study
Ragy R. Girgis, Seth C. Baker, Xiangling Mao, Roberto B. Gil, Daniel C. Javitt, Joshua T. Kantrowitz, Meng Gu, Daniel M. Spielman, Najate Ojeil, Xiaoyan Xu et al. · 2019 · Psychiatry Research
Glutamatergic hypofunction in medication-free major depression: Secondary effects of affective diagnosis and relationship to peripheral glutaminase
Toby Wise, Matthew John Taylor, Andrés Herane-Vives, Antonella Marino Gammazza, Francesco Cappello, David J. Lythgoe, Steven Williams, Allan Hunter Young, Anthony James Cleare, Danilo Arnone · 2018 · Journal of Affective Disorders
Transdiagnostic role of glutamate and white matter damage in neuropsychiatric disorders: A Systematic Review
Ines Luttenbacher, Angela Phillips, Reza Kazemi, Abed L. Hadipour, Isha Sanghvi, Julián A. Martínez-Agosto, Maheen M. Adamson · 2021 · Journal of Psychiatric Research
N-methyl-D-aspartate receptor availability in first-episode psychosis: a PET-MR brain imaging study
K. Beck, A. Arumuham, M. Veronese, Barbara Santangelo, C. McGinnity, J. Dunn, R. McCutcheon, S. Kaar, Nisha Singh, T. Pillinger et al. · 2021 · Translational Psychiatry
Potential diagnostic biomarkers for schizophrenia
Weihua Yue, Hailiang Huang, Jubao Duan · 2022 · Medical Review
The kynurenine pathway in treatment-resistant schizophrenia at the crossroads between pathophysiology and pharmacotherapy
Jacopo Sapienza, Giulia Agostoni, Stefano Dall’Acqua, Stefania Sut, Sofia Nasini, Francesca Martini, Anna Marchesi, Margherita Bechi, Mariachiara Buonocore, Federica Cocchi et al. · 2023 · Schizophrenia Research
Cerebral Glutamate and Gamma-Aminobutyric Acid Levels in Individuals at Ultra-high Risk for Psychosis and the Association With Clinical Symptoms and Cognition.
Christina Wenneberg, M. Nordentoft, E. Rostrup, L. Glenthøj, K. Bojesen, B. Fagerlund, C. Hjorthøj, K. Krakauer, T. D. Kristensen, Camilla Schwartz et al. · 2019 · Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
Emerging therapeutic targets for schizophrenia: a framework for novel treatment strategies for psychosis
Susan F. Sonnenschein, Anthony A. Grace · 2020 · Expert Opinion on Therapeutic Targets
Increased glutamate + glutamine levels in the thalamus of patients with essential tremor: A preliminary proton MR spectroscopic study
Gaetano Barbagallo, Gennarina Arabia, Fabiana Novellino, Rita Nisticò, Maria Salsone, Maurizio Morelli, Federico Rocca, Andrea Quattrone, Manuela Caracciolo, Umberto Sabatini et al. · 2017 · Parkinsonism & Related Disorders
Deconstructing Schizophrenia: Advances in Preclinical Models for Biomarker Identification
Judith A. Pratt, BRIAN J. MORRIS, Neil Dawson · 2018 · Current topics in behavioral neurosciences
Enhanced Dopamine in Prodromal Schizophrenia (EDiPS): a new animal model of relevance to schizophrenia
A. Petty, Xiao-Ying Cui, Y. Tesiram, D. Kirik, O. Howes, D. Eyles · 2019 · npj Schizophrenia
Feasibility of Glutamate and GABA Detection in Pons and Thalamus at 3T and 7T by Proton Magnetic Resonance Spectroscopy
Samaira Younis, Anders Hougaard, Casper Emil Christensen, Mark Bitsch Vestergaard, Esben Thade Petersen, Vincent O. Boer, Olaf Bjarne Paulson, Messoud Ashina, Anouk Marsman, Henrik B. W. Larsson · 2020 · Frontiers in Neuroscience
The Roles of hnRNP Family in the Brain and Brain-Related Disorders
Caroline Brandão‐Teles, André Saraiva Leão Marcelo Antunes, Talita Aparecida de Moraes Vrechi, Daniel Martins‐de‐Souza · 2023 · Molecular Neurobiology
Thalamocortical dysrhythmia in patients with schizophrenia spectrum disorder and individuals at clinical high risk for psychosis
Minah Kim, Tak Hyung Lee, Hyungyou Park, Sun‐Young Moon, Silvia Kyungjin Lho, Jun Soo Kwon · 2021 · Neuropsychopharmacology
AMPA receptors in schizophrenia: A systematic review of postmortem studies on receptor subunit expression and binding
Kengo Yonezawa, Hideaki Tani, Shinichiro Nakajima, Nobuhiro Nagai, Teruki Koizumi, Tomoyuki Miyazaki, Masaru Mimura, Takuya Takahashi, Hiroyuki Uchida · 2022 · Schizophrenia Research
Proton magnetic resonance spectroscopic imaging of gray and white matter in bipolar-I and schizophrenia
Juan Bustillo, Thomas Jones, Clifford Qualls, Leslie Chavez, Denise S. Lin, Rhoshel Lenroot, Charles Gasparovic · 2018 · Journal of Affective Disorders
Anterior Cingulate Cortex Glutamate Levels Are Related to Response to Initial Antipsychotic Treatment in Drug-Naive First-Episode Schizophrenia Patients
Jinguang Li, Honghong Ren, Ying Hé, ZongChang Li, Xiaoqian Ma, Yuan Liu, Lijun Ouyang, Jun Zhou, Dong Wang, Chunwang Li et al. · 2020 · Frontiers in Psychiatry
Risk-Conferring Glutamatergic Genes and Brain Glutamate Plus Glutamine in Schizophrenia
Juan Bustillo, Veena Patel, Thomas Jones, Rex Eugene Jung, Nattida Payaknait, Clifford Qualls, José M. Cañive, Jingyu Liu, Nora I. Perrone‐Bizzozero, Vince D. Calhoun et al. · 2017 · Frontiers in Psychiatry
Glutamate metabolites in treatment resistant schizophrenia: A meta-analysis and systematic review of 1H-MRS studies
Vijay Kumar, Shayanth Manchegowda, Arpitha Jacob, Naren Prahalada Rao · 2020 · Psychiatry Research Neuroimaging
Sodium nitroprusside treatment for psychotic symptoms and cognitive deficits of schizophrenia: A randomized, double-blind, placebo-controlled trial
Xiujuan Wang, Jingyuan Zhao, Yunqing Hu, Zhiqiang Jiao, Yanli Lu, Minli Ding, Yanna Kou, Benliang Li, Fancui Meng, Hongzu Zhao et al. · 2018 · Psychiatry Research
Glutamate levels in the anterior cingulate cortex in un-medicated first episode psychosis: a proton magnetic resonance spectroscopy study
Faith Borgan, Sameer Jauhar, Robert Ali McCutcheon, Fiona Pepper, Maria Rogdaki, David J. Lythgoe, Oliver David Howes · 2019 · Scientific Reports
The role of glutamate receptors and their interactions with dopamine and other neurotransmitters in the development of tardive dyskinesia: preclinical and clinical results
Anna Maria Szota, Jørgen Scheel‐Krüger · 2020 · Behavioural Pharmacology
Epigenetic Targets in Schizophrenia Development and Therapy
Agnieszka Wawrzczak‐Bargieła, Wiktor Bilecki, Marzena Maćkowiak · 2023 · Brain Sciences
Spontaneous Brain Activity Alterations in First-Episode Psychosis: A Meta-analysis of Functional Magnetic Resonance Imaging Studies
Giulia Cattarinussi, David Antonio Grimaldi, Fabio Sambataro · 2023 · Schizophrenia Bulletin
Exploring aperiodic activity in first episode schizophrenia spectrum psychosis: A resting-state EEG analysis
Ruby J. Earl, Talitha C. Ford, Jarrad A. G. Lum, Peter G. Enticott, Aron T. Hill · 2024 · Brain Research
Glutamatergic metabolites among adolescents at risk for psychosis
Caroline Demro, Laura M. Rowland, S. Andrea Wijtenburg, James A. Waltz, James M. Gold, Emily R. Kline, Elizabeth Thompson, Gloria M. Reeves, Liyi Elliot Hong, Jason Eric Schiffman · 2017 · Psychiatry Research
Magnetic resonance spectroscopy studies in subjects with high risk for psychosis: A meta-analysis and review
Bruno Roméo, Amélie Petillion, Catherine Martelli, Amine Benyamina · 2020 · Journal of Psychiatric Research
Resting-state brain functional alterations and their genetic mechanisms in drug-naive first-episode psychosis
Qian Li, Xiaotao Xu, Yinfeng Qian, Huanhuan Cai, Wenming Zhao, Jiajia Zhu, Yongqiang Yu · 2023 · Schizophrenia
Glutamatergic and GABAergic reactivity and cognition in 22q11.2 deletion syndrome and healthy volunteers: A randomized double-blind 7-Tesla pharmacological MRS study
Claudia Vingerhoets, Desmond H. Y. Tse, Mathilde J.F. van Oudenaren, Dennis Hernaus, Esther D.A. van Duin, Janneke Zinkstok, Johannes Gerardus Ramaekers, Jacobus F.A. Jansen, Grainne Mary McAlonan, Thérèse van Amelsvoort · 2020 · Journal of Psychopharmacology
Glutamate-Based Therapeutic Strategies for Schizophrenia: Emerging Approaches Beyond Dopamine
Mihaela Fadgyas Stănculete, Octavia Căpățînă · 2025 · International Journal of Molecular Sciences
Decrease in gamma-band auditory steady-state response in patients with treatment-resistant schizophrenia
Kamiyu Ogyu, Karin Matsushita, Shiori Honda, Masataka Wada, Shunsuke Tamura, Kazumasa Takenouchi, Yui Tobari, Keisuke Kusudo, Hideo Kato, Teruki Koizumi et al. · 2023 · Schizophrenia Research
The impact of cannabidiol treatment on resting state functional connectivity, prefrontal metabolite levels and reward processing in recent-onset patients with a psychotic disorder
Ruben van Boxel, Shiral S. Gangadin, Hella Janssen, Sanne J. van der Steur, Lucia J.C. van der Vinne, Lon Dortants, Teuntje A. D. Pelgrim, Luc W.R. Draisma, Ruth Tuura, Pim B. van der Meer et al. · 2023 · Journal of Psychiatric Research
A polymorphism in the glutamate metabotropic receptor 7 is associated with cognitive deficits in the early phases of psychosis
Boris Chaumette, Sarojini M. Sengupta, Martín Lepage, ASHOK K. MALLA, Srividya N. Iyer, Oussama Kébir, Patrick A. Dion, Guy Armand Rouleau, Marie‐Odile Krebs, Jai L. Shah et al. · 2020 · Schizophrenia Research
Lipid‐suppressed and tissue‐fraction corrected metabolic distributions in human central brain structures using 2D 1 H magnetic resonance spectroscopic imaging at 7 T
Alex A. Bhogal, Tommy A.A. Broeders, Lisan M. Morsinkhof, Mirte Edens, S Nassirpour, P Chang, Dennis W. J. Klomp, Christiaan H. Vinkers, Jannie P. Wijnen · 2020 · Brain and Behavior
Markers of Schizophrenia—A Critical Narrative Update
Beata Galińska-Skok, Napoleon Waszkiewicz · 2022 · Journal of Clinical Medicine
In Vivo Reactive Astrocyte Imaging in Patients With Schizophrenia Using Fluorine 18–Labeled THK5351
Minah Kim, Woori Choi, Sunah Choi, Harin Oh, Jongrak Kim, Jungha Lee, Su-Jin An, Jun Seo Hwang, Yun‐Sang Lee, In Chan Song et al. · 2024 · JAMA Network Open
Social isolation stress and chronic glutathione deficiency have a common effect on the glutamine‐to‐glutamate ratio and myo‐inositol concentration in the mouse frontal cortex
Alberto Corcoba, Rolf Gruetter A, Kim Q., João M. N. Duarte · 2017 · Journal of Neurochemistry
Dimensional distribution of cortical abnormality across antipsychotics treatment-resistant and responsive schizophrenia
Takashi Itahashi, Yoshihiro Noda, Yusuke Iwata, Ryosuke Tarumi, Sakiko Tsugawa, Eric Plitman, Shiori Honda, Fernando Caravaggio, Julia Kim, Karin Matsushita et al. · 2021 · NeuroImage Clinical
Glutamate connectivity associations converge upon the salience network in schizophrenia and healthy controls
Robert Ali McCutcheon, Toby Pillinger, Maria Rogdaki, Juan Bustillo, Oliver David Howes · 2021 · Translational Psychiatry
Dopamine and Neuroinflammation in Schizophrenia – Interpreting the Findings from Translocator Protein (18kDa) PET Imaging
Sotiria Maria Iliopoulou, Stergios Tsartsalis, Stefan Kaiser, P. Millet, Benjamin B. Tournier · 2021 · Neuropsychiatric Disease and Treatment
Large-Scale Thalamocortical Triple Network Dysconnectivities in Patients With First-Episode Psychosis and Individuals at Risk for Psychosis
Minah Kim, Taekwan Kim, Minji Ha, Harin Oh, Sun‐Young Moon, Jun Soo Kwon · 2022 · Schizophrenia Bulletin
Increased Metabolic Potential, Efficacy, and Safety of Emerging Treatments in Schizophrenia
Jonathan M. Meyer, Christoph Ulrich Correll · 2023 · CNS Drugs
Striatal neurometabolite levels in patients with schizophrenia undergoing long-term antipsychotic treatment: A proton magnetic resonance spectroscopy and reliability study
Eric Plitman, Sofia Chavez, Shinichiro Nakajima, Yusuke Iwata, Jun Ku Chung, Fernando Caravaggio, Julia N. Kim, Youssef Alshehri, M. Mallar Chakravarty, Vincenzo De Luca et al. · 2018 · Psychiatry Research Neuroimaging
Glutamate- and GABA-Modulated Connectivity in Auditory Hallucinations—A Combined Resting State fMRI and MR Spectroscopy Study
S. Weber, H. Hjelmervik, A. Craven, E. Johnsen, R. Kroken, E. Løberg, L. Ersland, K. Kompus, K. Hugdahl · 2021 · Frontiers in Psychiatry
Common and Distinct Alterations of Cognitive Function and Brain Structure in Schizophrenia and Major Depressive Disorder: A Pilot Study
Mengying Ma, Yuyanan Zhang, Xiao Zhang, Hao Yan, Dai Zhang, Weihua Yue · 2021 · Frontiers in Psychiatry
Magnetic Resonance Spectroscopy for Psychiatry
John D. Port · 2019 · Neuroimaging Clinics of North America
Effect of single dose N-acetylcysteine administration on resting state functional connectivity in schizophrenia
Grant McQueen, Aderlee Lay, John Lally, Anthony S. Gabay, Tracy Collier, David J. Lythgoe, Gareth J. Barker, James M. Stone, Philip K. McGuire, James Hunter MacCabe et al. · 2019 · Psychopharmacology
Metabolite abnormalities in psychosis risk: A meta-analysis of proton magnetic resonance spectroscopy studies
Yong-ming Wang, Yahui Xiao, Wen-lan Xie · 2020 · Asian Journal of Psychiatry
Oxidative Stress-Mediated Neuroinflammation in the Pathophysiology of Schizophrenia
Mateusz Trubalski, Agnieszka Markiewicz-Gospodarek, Marta Żerebiec, Julia Poleszak, Miłosz Szczotka, Renata Markiewicz, Bartosz Łoza, Sylwia Szymańczyk · 2025 · International Journal of Molecular Sciences
A longitudinal investigation of GABA, glutamate, and glutamine across the insula during antipsychotic treatment of first-episode schizophrenia
Susan F. Sonnenschein, Ahmad Mayeli, Victor E. Yushmanov, Annie Blazer, Finnegan J. Calabro, Maria I. Perica, Will Foran, Beatríz Luna, Hoby P. Hetherington, Fabio Ferrarelli et al. · 2022 · Schizophrenia Research
Visual surround suppression at the neural and perceptual levels
Yang Li, Weifeng Dai, Tian Wang, Yujie Wu, Fei Dou, Dajun Xing · 2023 · Cognitive Neurodynamics
Glutamate homeostasis in the adult rat prefrontal cortex is altered by cortical docosahexaenoic acid accrual during adolescence: An in vivo 1H MRS study
Robert K. McNamara, Ruth Asch, Jennifer D. Schurdak, Diana M. Lindquist · 2017 · Psychiatry Research Neuroimaging
Schizophrenia: synthetic strategies and recent advances in drug design
Maria Azmanova, Anaïs Pitto‐Barry, Nicolas P. E. Barry · 2018 · MedChemComm